Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000429379 | SCV000527854 | likely benign | not specified | 2017-08-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000544989 | SCV000641226 | benign | MOGS-congenital disorder of glycosylation | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003422324 | SCV004155077 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | MOGS: BS1 |
ARUP Laboratories, |
RCV000544989 | SCV004563055 | benign | MOGS-congenital disorder of glycosylation | 2023-11-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003922463 | SCV004746609 | benign | MOGS-related condition | 2019-09-09 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |